EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Intermittent glucocorticoid treatment improves muscle metabolism via the PGC1α/Lipin1 axis in an aging-related sarcopenia model

Ashok D Prabakaran, Kevin McFarland, Karen Miz, Hima Bindu Durumutla, Kevin Piczer, Fadoua El Abdellaoui Soussi, Hannah Latimer, Cole Werbrich, Hyun-Jy Chung, N Scott Blair, Douglas P Millay, Andrew J Morris und 3 weitere

Journal of Clinical Investigation · 2024

DOI: 10.1172/jci177427 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von Ashok D Prabakaran und 14 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Cardiovascular Biology, Heart Institute, Cincinnati Children's Hospital Medical Center (CCHMC) and Department Pediatrics, University of Cin…. Hauptthemen laut MEDLINE: Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Sarcopenia, Aging, Phosphatidate Phosphatase. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, NIA NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sarcopenia burdens the older population through loss of muscle energy and mass, yet treatments to functionally rescue both parameters are lacking. The glucocorticoid prednisone remodels muscle metabolism on the basis of frequency of intake, but its mechanisms in sarcopenia are unknown. We found that once-weekly intermittent prednisone administration rescued muscle quality in aged 24-month-old mice to a level comparable to that seen in young 4-month-old mice. We discovered an age- and sex-independent glucocorticoid receptor transactivation program in muscle encompassing peroxisome proliferator–activated receptor γ coactivator 1 α (PGC1α) and its cofactor Lipin1. Treatment coordinately improved mitochondrial abundance through isoform 1 and muscle mass through isoform 4 of the myocyte-specific PGC1α, which was required for the treatment-driven increase in carbon shuttling from glucose oxidation to amino acid biogenesis. We also probed myocyte-specific Lipin1 as a nonredundant factor coaxing PGC1α upregulation to the stimulation of both oxidative and anabolic effects. Our study unveils an aging-resistant druggable program in myocytes for the coordinated rescue of energy and mass in sarcopenia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaSarcopeniaAgingPhosphatidate PhosphataseGlucocorticoidsMuscle, SkeletalAnimalsMiceMaleDisease Models, AnimalFemale

Stichwörter der Autor:innen

AgingEpigeneticsMitochondriaMuscleMuscle biology

Substanzen

Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPpargc1a protein, mouseLpin1 protein, mousePhosphatidate PhosphataseGlucocorticoids

Autor:innen und Institutionen

  • Molecular Cardiovascular Biology, Heart Institute, Cincinnati Children's Hospital Medical Center (CCHMC) and Department Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Department Pharmacology and Toxicology, University of Arkansas for Medical Sciences (UAMS) College of Medicine and Central Arkansas VA Healthcare System, Little Rock, Arkansas, USA.
  • Department Neuroscience, Cell Biology, and Anatomy, University of Texas Medical Branch (UTMB), Galveston, Texas, USA.
  • Department of Medicine, Center for Human Nutrition, Washington University in St. Louis, Missouri, USA.

Förderung

  • BLRD VA
  • NIA NIH HHS
  • NHLBI NIH HHS
  • NIDDK NIH HHS
  • National Institutes of Health

Zitieren

APA

Prabakaran, A. D., McFarland, K., Miz, K., Durumutla, H. B., Piczer, K., El Abdellaoui Soussi, F., Latimer, H., Werbrich, C., Chung, H. J., Blair, N. S., Millay, D. P., Morris, A. J., Prideaux, B., Finck, B. N., & Quattrocelli, M. (2024). Intermittent glucocorticoid treatment improves muscle metabolism via the PGC1α/Lipin1 axis in an aging-related sarcopenia model. Journal of Clinical Investigation. https://doi.org/10.1172/jci177427

Vancouver

Prabakaran AD, McFarland K, Miz K, Durumutla HB, Piczer K, El Abdellaoui Soussi F, et al. Intermittent glucocorticoid treatment improves muscle metabolism via the PGC1α/Lipin1 axis in an aging-related sarcopenia model. Journal of Clinical Investigation. 2024. doi:10.1172/jci177427

BibTeX
@article{Prabakaran2024,
  author = {Prabakaran, Ashok D and McFarland, Kevin and Miz, Karen and Durumutla, Hima Bindu and Piczer, Kevin and El Abdellaoui Soussi, Fadoua and Latimer, Hannah and Werbrich, Cole and Chung, Hyun-Jy and Blair, N Scott and Millay, Douglas P and Morris, Andrew J and Prideaux, Brendan and Finck, Brian N and Quattrocelli, Mattia},
  title = {Intermittent glucocorticoid treatment improves muscle metabolism via the PGC1α/Lipin1 axis in an aging-related sarcopenia model},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  doi = {10.1172/jci177427}
}
Kostenlos starten →